Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
$0.00
$0.00
$0.26
N/A135.11800 shsN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$1.00
$0.82
$0.22
$3.11
$33.96M1.96167,434 shs504 shs
RPBC
Redpoint Bio
$0.00
+∞
$0.00
$0.00
$0.00
N/AN/A101,150 shs200,000 shs
Viralytics Limited stock logo
VRACY
Viralytics
$3.75
$0.00
$1.50
$4.10
N/AN/A247 shsN/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
0.00%0.00%0.00%0.00%0.00%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.00%0.00%+11.11%+150.00%-66.67%
RPBC
Redpoint Bio
0.00%0.00%0.00%0.00%0.00%
Viralytics Limited stock logo
VRACY
Viralytics
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
N/AN/AN/AN/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.2294 of 5 stars
0.03.00.00.00.01.70.0
RPBC
Redpoint Bio
N/AN/AN/AN/AN/AN/AN/AN/A
Viralytics Limited stock logo
VRACY
Viralytics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
0.00
N/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.00
N/AN/AN/A
RPBC
Redpoint Bio
0.00
N/AN/AN/A
Viralytics Limited stock logo
VRACY
Viralytics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
$2.05MN/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$116.61M0.29$0.33 per share3.03N/A
RPBC
Redpoint Bio
N/AN/AN/AN/AN/AN/A
Viralytics Limited stock logo
VRACY
Viralytics
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
-$6.08MN/A0.00N/AN/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$9.28MN/A0.00N/AN/AN/AN/AN/A
RPBC
Redpoint Bio
N/AN/A0.00N/AN/AN/AN/AN/A
Viralytics Limited stock logo
VRACY
Viralytics
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
N/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/AN/AN/A
RPBC
Redpoint Bio
N/AN/AN/AN/AN/A
Viralytics Limited stock logo
VRACY
Viralytics
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
N/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
87.46%
RPBC
Redpoint Bio
N/A
Viralytics Limited stock logo
VRACY
Viralytics
N/A

Insider Ownership

CompanyInsider Ownership
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
N/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
7.60%
RPBC
Redpoint Bio
11.51%
Viralytics Limited stock logo
VRACY
Viralytics
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Affinity Energy and Health Limited stock logo
ALGXY
Affinity Energy and Health
N/AN/AN/ANot Optionable
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
39033.96 million31.38 millionOptionable
RPBC
Redpoint Bio
N/AN/AN/ANot Optionable
Viralytics Limited stock logo
VRACY
Viralytics
N/AN/AN/ANot Optionable

Recent News About These Companies

Oncolytics: the dawn of a new era in cancer treatment
Viralytics lifted by FDA panel verdict on T-Vec
Reflection and refraction of light - CCEA
ViewRay, Inc. (VRAY)
50% Off Ray-Ban Promo Codes - March
What is Billy Ray Cyrus' net worth?
The Ray D'Arcy Show
Ray, MI Weather Conditions
oncolytic virus
Rachael Ray Cookware Reviews
Lenses and ray diagrams - OCR Gateway
Arizona State Athletic Director Ray Anderson resigns
Top broker names 3 healthcare shares to buy

Media Sentiment Over Time

Affinity Energy and Health stock logo

Affinity Energy and Health OTCMKTS:ALGXY

Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.

Luna Innovations stock logo

Luna Innovations NASDAQ:LUNA

$1.00 0.00 (0.00%)
As of 07/31/2025 12:49 PM Eastern

Luna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.

Redpoint Bio OTCMKTS:RPBC

$0.0001 +0.00 (+∞)
As of 07/23/2019

Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.

Viralytics stock logo

Viralytics OTCMKTS:VRACY

Viralytics Limited, a biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies in Australia and internationally. The company's lead investigational product is CAVATAK, a proprietary formulation of an oncolytic common cold virus that is in Phase Ib clinical trials for the treatment of melanoma, and lung and bladder cancer; Phase II clinical trials for the treatment of late stage melanoma; and in pre-clinical studies for the treatment of prostate and breast cancer, multiple myeloma, pancreatic cancer, malignant glioma, acute myeloid leukemia, and chronic lymphocytic leukemia. It is also developing EVATAK to treat ovarian, prostate, and gastric cancer. The company was formerly known as Psiron Ltd. and changed its name to Viralytics Limited in December 2006. Viralytics Limited is headquartered in Sydney, Australia. As of June 20, 2018, Viralytics Limited operates as a subsidiary of Merck Sharp & Dohme (Holdings) Pty Ltd.